Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04291469Unknown
Randomised, double-blind trial (3 arms), sponsored by First Affiliated Hospital of Xi'an Jiaotong University. Primary endpoint: Positive and Negative Syndrome Scale at 26 weeks. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04291469.